"Myositis Ossificans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by bony deposits or the ossification of muscle tissue.
| Descriptor ID |
D009221
|
| MeSH Number(s) |
C05.651.594.638
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myositis Ossificans".
Below are MeSH descriptors whose meaning is more specific than "Myositis Ossificans".
This graph shows the total number of publications written about "Myositis Ossificans" by people in this website by year, and whether "Myositis Ossificans" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myositis Ossificans" by people in Profiles.
-
The Efficacy of CT Temporal Subtraction Images for Fibrodysplasia Ossificans Progressiva. Tomography. 2023 04 03; 9(2):768-775.
-
Simulation-Guided Tracheotomy in a Patient With Fibrodysplasia Ossificans Progressiva. Laryngoscope. 2019 04; 129(4):812-817.
-
Difficult airway management in a child with fibrodysplasia ossificans progressiva in status asthmaticus. J Clin Anesth. 2018 12; 51:8-9.
-
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants. J Med Chem. 2014 Oct 09; 57(19):7900-15.
-
Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010 Dec; 16(12):1400-6.
-
BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008 Dec; 14(12):1363-9.
-
Pseudomalignant myositis ossificans of the proximal phalanx: a report of two cases. J Surg Orthop Adv. 2006; 15(2):105-10.
-
Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 1998 Jan; (346):38-45.
-
Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. Hum Pathol. 1997 Mar; 28(3):339-43.
-
MR imaging of myositis ossificans: variable patterns at different stages. J Magn Reson Imaging. 1995 May-Jun; 5(3):287-92.